Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04065152
Title Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma (KAPVEC)
Acronym KAPVEC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.